Hyperuricemia

• FDA label_change · 2025-10-16
  FDA Approved: ALLOPURINOL — Supplemental Application (Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.)

  FDA granted a supplemental approval for ALLOPURINOL submitted by Heritage Pharmaceuticals d/b/a Avet Pharmaceuticals Inc. to update the prod…

• FDA label_change · 2024-03-08
  FDA Approved: ALLOPURINOL — Supplemental Application (Harman Finochem Limited)

  FDA approved a supplemental application for Allopurinol, approving changes to the labeling for Harman Finochem Limited's generic Allopurinol…

• FDA label_change · 2024-01-29
  FDA Approved: ALLOPURINOL — Supplemental Application (Unichem Pharmaceuticals (USA), Inc.)

  FDA approved a supplemental application for Allopurinol submitted by Unichem Pharmaceuticals (USA), Inc., resulting in changes to the produc…

• FDA label_change · 2019-04-23
  FDA Approved: ALLOPURINOL — Supplemental Application (Zydus Lifesciences Limited)

  FDA approved a supplemental application for allopurinol submitted by Zydus Lifesciences Limited, indicating changes to the product labeling.

• FDA label_change · 2018-02-06
  FDA Approved: ULORIC — Supplemental Application (Takeda Pharmaceuticals America, Inc.)

  FDA approved a supplemental application for ULORIC (febuxostat) submitted by Takeda Pharmaceuticals America, Inc. The supplemental action pe…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.